Greg Miraglia and Jeff Nardinelli of Quinn Emanuel Urquhart & Sullivan LLP discuss the potential and successes of low-orbit ...

Discover how advanced water analytics optimize ultra-pure water use in semiconductor fabs, boosting yield and reducing environmental impact.

Eli Lilly will invest more than $1.2bn into its manufacturing site in Puerto Rico, as the drugmaker looks to assemble a ...

Curia’s global API aseptic processing manufacturing network has served a broad portfolio of customers worldwide for more than 20 years. This investment positions the company to support increasingly ...

Empowering Next-Gen Bioconjugates (ADCs/XDCs): Apeloa provides high-purity linkers and comprehensive chemistry services to accelerate your ADC, targeted conjugation, and peptide drug development ...

The CDMO’s latest investment will boost capacity at its Charles City, IA facility by 40%, underscoring Cambrex’s focus on ...

Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments.

New state-of-the-art active pharmaceutical ingredient (API) facility will manufacture immunology, oncology and neuroscience medicines Facility expected to be fully operational and serving patients by ...

After months of merchant frustration over securing the required API key for website-reported local inventory feeds via Google Tag Manager, Google has now confirmed a straightforward process: Why we ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...